News
Postal Realty Trust (PSTL) Q4 FFO Match Estimates
Postal Realty Trust (PSTL) came out with quarterly funds from operations (FFO) of $0.33 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.35 per share a year ago
MGE (MGEE) Meets Q4 Earnings Estimates
MGE (MGEE) came out with quarterly earnings of $0.64 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.61 per share a year ago. These figures are adjusted for
Marqeta (MQ) Reports Break-Even Earnings for Q4
Marqeta (MQ) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.05 per share a year ago. These figures are
New Mountain Finance (NMFC) Q4 Earnings Meet Estimates
New Mountain Finance (NMFC) came out with quarterly earnings of $0.32 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.32 per share a year ago. These figures
Interparfums (IPAR) Beats Q4 Earnings and Revenue Estimates
Interparfums (IPAR) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.82 per share a year ago. These
Light & Wonder (LNWO) Surpasses Q4 Earnings Estimates
Light & Wonder (LNWO) came out with quarterly earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.42 per share a year ago. These
Luxfer (LXFR) Beats Q4 Earnings Estimates
Luxfer (LXFR) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.29 per share a year ago. These figures are
LTC Properties (LTC) Tops Q4 FFO Estimates
LTC Properties (LTC) came out with quarterly funds from operations (FFO) of $0.7 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to FFO of $0.72 per share a year
Hyliion Holdings Corp. (HYLN) Reports Q4 Loss, Misses Revenue Estimates
Hyliion Holdings Corp. (HYLN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.08 per share a year ago. These
Globus Medical (GMED) Surpasses Q4 Earnings and Revenue Estimates
Globus Medical (GMED) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.84 per share a year ago. These
FrontView REIT, Inc. (FVR) Meets Q4 FFO Estimates
FrontView REIT, Inc. (FVR) came out with quarterly funds from operations (FFO) of $0.31 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.27 per share a year ago
Flywire (FLYW) Reports Break-Even Earnings for Q4
Flywire (FLYW) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.12 per share a year ago. These figures are
Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates
Corcept Therapeutics (CORT) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.26 per share a year ago
Evolent Health (EVH) Q4 Earnings Top Estimates
Evolent Health (EVH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.02 per share a year ago. These
Everus Construction Group, Inc. (ECG) Q4 Earnings and Revenues Top Estimates
Everus Construction Group, Inc. (ECG) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.67 per share a
Carlyle Secured Lending, Inc. (CGBD) Q4 Earnings and Revenues Miss Estimates
Carlyle Secured Lending, Inc. (CGBD) came out with quarterly earnings of $0.33 per share, missing the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.47 per share a year
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates
AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.11 per share a year ago. These
Archrock Inc. (AROC) Q4 Earnings and Revenues Beat Estimates
Archrock Inc. (AROC) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.35 per share a year ago. These
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates
CeriBell, Inc. (CBLL) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.4 per share a year ago. These figures
Slide Insurance Holdings, Inc. (SLDE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Slide Insurance Holdings, Inc. (SLDE) reported $347.01 million in revenue for the quarter ended December 2025, representing no change year over year. EPS of $1.23 for the same period compares to $0
Resideo Technologies (REZI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Resideo Technologies (REZI) reported $1.9 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 2%. EPS of $0.50 for the same period compares to $0.59 a
Merit Medical (MMSI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended December 2025, Merit Medical (MMSI) reported revenue of $393.94 million, up 10.9% over the same period last year. EPS came in at $1.04, compared to $0.93 in the year-ago
Compared to Estimates, Realty Income Corp. (O) Q4 Earnings: A Look at Key Metrics
For the quarter ended December 2025, Realty Income Corp. (O) reported revenue of $1.49 billion, up 11% over the same period last year. EPS came in at $1.08, compared to $0.23 in the year-ago
Here's What Key Metrics Tell Us About Revolve Group (RVLV) Q4 Earnings
For the quarter ended December 2025, Revolve Group (RVLV) reported revenue of $324.37 million, up 10.4% over the same period last year. EPS came in at $0.26, compared to $0.17 in the year-ago
Jazz (JAZZ) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended December 2025, Jazz Pharmaceuticals (JAZZ) reported revenue of $1.2 billion, up 10.1% over the same period last year. EPS came in at $6.64, compared to $6.60 in the year-ago


